Teneliximab

Teneliximab
Monoclonal antibody
Type	Whole antibody
Source	Chimeric (mouse/human)
Target	CD40
Clinical data
ATC code	none;
Identifiers
CAS Number	299423-37-3 ;
ChemSpider	none;
UNII	G0MV33WQ6V;
KEGG	D06071 ;
	(what is this?)

Teneliximab is a chimeric monoclonal antibody^[1] binding to the immune stimulatory protein CD40. As of 2009, it has not entered clinical trials.^[2]

References[]

^ International Nonproprietary Names For Pharmaceutical Substances
^ Grewal IS, ed. (January 15, 2009). Therapeutic Targets of the TNF Superfamily (Advances in Experimental Medicine and Biology). Springer. p. 22. ISBN 978-0-387-89519-2.

This monoclonal antibody–related article is a stub. You can help Wikipedia by .

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by .

[1] International Nonproprietary Names For Pharmaceutical Substances

[2] Grewal IS, ed. (January 15, 2009). Therapeutic Targets of the TNF Superfamily (Advances in Experimental Medicine and Biology). Springer. p. 22. ISBN 978-0-387-89519-2.

[1]

[2]